- Home
- QNCX vs BIRD Comparison
QNCX vs BIRD Comparison
Compare QNCX & BIRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QNCX
- BIRD
- Stock Information
- Founded
- QNCX 2012
- BIRD 2015
- Country
- QNCX United States
- BIRD United States
- Employees
- QNCX N/A
- BIRD N/A
- Industry
- QNCX Biotechnology: Biological Products (No Diagnostic Substances)
- BIRD Apparel
- Sector
- QNCX Health Care
- BIRD Consumer Discretionary
- Exchange
- QNCX Nasdaq
- BIRD Nasdaq
- Market Cap
- QNCX 44.0M
- BIRD 50.7M
- IPO Year
- QNCX 2019
- BIRD 2021
- Fundamental
- Price
- QNCX $1.02
- BIRD $4.86
- Analyst Decision
- QNCX Strong Buy
- BIRD Buy
- Analyst Count
- QNCX 5
- BIRD 3
- Target Price
- QNCX $8.00
- BIRD $12.00
- AVG Volume (30 Days)
- QNCX 138.1K
- BIRD 75.6K
- Earning Date
- QNCX 05-12-2025
- BIRD 05-07-2025
- Dividend Yield
- QNCX N/A
- BIRD N/A
- EPS Growth
- QNCX N/A
- BIRD N/A
- EPS
- QNCX N/A
- BIRD N/A
- Revenue
- QNCX N/A
- BIRD $189,757,000.00
- Revenue This Year
- QNCX N/A
- BIRD N/A
- Revenue Next Year
- QNCX N/A
- BIRD $4.60
- P/E Ratio
- QNCX N/A
- BIRD N/A
- Revenue Growth
- QNCX N/A
- BIRD N/A
- 52 Week Low
- QNCX $0.51
- BIRD $3.93
- 52 Week High
- QNCX $2.45
- BIRD $18.34
- Technical
- Relative Strength Index (RSI)
- QNCX 26.91
- BIRD 42.42
- Support Level
- QNCX $0.93
- BIRD $4.21
- Resistance Level
- QNCX $1.26
- BIRD $5.59
- Average True Range (ATR)
- QNCX 0.10
- BIRD 0.59
- MACD
- QNCX -0.03
- BIRD -0.11
- Stochastic Oscillator
- QNCX 18.03
- BIRD 29.90
About QNCX Quince Therapeutics Inc.
Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.
About BIRD Allbirds Inc.
Allbirds Inc is a lifestyle brand that innovates with naturally derived materials to make footwear and apparel products in a better way, while treading lighter on the planet. Its primary source of revenue is from sales of shoes and apparel products. The majority of the revenue is derived from United States.